ERG and metastatic neoplasm: While the TMPRSS2:ERG fusion gene is an early event of prostate tumorigenesis and associated with progression from HGPIN to adenocarcinoma, the role of this genetic alteration in more advanced and metastatic disease has also been recently investigated.